HTFL insider ownership: who sold, why, and what they still hold

What stands out

Jeffrey Lightcap bought 40K shares for $1.1M, first on Dec 16, 2025. These are the first purchases by current officers or directors in the filings on record.Purchase, Dec 16, 2025

Outside holder Bain Capital Life Sciences Investors, LLC, a 10% owner and not part of management, sold $115M of stock.Largest sale, Feb 4, 2026

Selling picked up in the last 90 days: officers and directors sold 304K shares, against an average of 132K per 90 days earlier in the period. Most of it was John Farquhar (176K shares in the last 90 days) and Vikram Verghese (99K shares in the last 90 days); 100% of these sales were under disclosed plans.John Farquhar: largest recent sale, Oct 12, 2026 · Vikram Verghese: largest recent sale, Sep 11, 2026

A share of stake is shown for 0 of the 4 officers and directors who sold. 10 are left out

Left out: Jeffrey Lightcap, John Farquhar, William Weldon, Timothy Barabe, Campbell Rogers, Vikram Verghese, Julie Cullivan, Casey Tansey, Marie Jones and Wayne Riley (share of stake is being verified).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

John Farquhar

Chief Executive Officer, Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$12.9MDisclosed plan

Campbell Rogers

Chief Medical Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$6.7MDisclosed plan

Vikram Verghese

Chief Financial Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$5.0MDisclosed plan

Julie Cullivan

Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$447KDisclosed plan

Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled

Recent activity

Past 30 days, Sep 17, 2026 to Oct 16, 2026

Oct 12, 2026John Farquhar sold 39K shares ($1.9M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
John Farquhar Chief Executive Officer, Director	38,900	$49.57	n/a	n/a	Oct 12, 2026	Oct 14, 2026

Sep 18, 20262 executives sold 36K shares ($1.8M) under a disclosed trading plan. 13K shares came in from vesting or option exercises the same day, so their combined holdings fell by 23K net.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Campbell Rogers Chief Medical Officer	19,682	$50.15	n/a	n/a	Sep 18, 2026	Sep 21, 2026
Vikram Verghese Chief Financial Officer	16,766	$50.75	n/a	n/a	Sep 18, 2026	Sep 18, 2026

Sep 17, 2026Vikram Verghese sold 7.6K shares ($380K) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Vikram Verghese Chief Financial Officer	7,579	$50.11	n/a	n/a	Sep 17, 2026	Sep 18, 2026

"% of total stake" is the shares in an event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings are not confirmed, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Outside holders, reported separately

Bain Capital Life Sciences Investors, LLC sold $115M in the past 12 months. Large shareholders and the funds or companies that board members represent are not part of management, so they are left out of the figures above.

Details

Common questions

Is the Heartflow, Inc. CEO selling stock?

Yes. John Farquhar sold 350K shares ($12.9M) in the past 12 months, all of it under a trading plan disclosed in the filings.

Why are Heartflow, Inc. insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 100% of sales by value ran under 10b5-1 trading plans disclosed in the filings. A trading plan schedules sales in advance.

Are any Heartflow, Inc. insiders buying?

Yes. 1 officer or director reported 1 purchase in the past 12 months (Form 4 code P; rows the filings describe as reinvested dividends, plan purchases, private deals or moves into the person's own trust are not counted).

The evidence

Who sold4 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
John Farquhar Chief Executive Officer, Director	$12.9M 350K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Campbell Rogers Chief Medical Officer	$6.7M 242K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Vikram Verghese Chief Financial Officer	$5.0M 99K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Julie Cullivan Director	$447K 17K shares	Not confirmed share of stake is being verified. Why	Disclosed plan

Board members representing outside shareholders, reported separately: Casey Tansey, Jeffrey Lightcap. Details

Outside holder, reported separately: Bain Capital Life Sciences Investors, LLC (a 10% owner, not part of management). Sold $115M (4.00M shares) from Feb 4, 2026 to Apr 30, 2026. Latest filing

Outside holder, reported separately: HealthCor Partners Management LP (an outside shareholder, not part of management). No open-market sales reported in the period. Latest filing

The full ownership picture0 of 10 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 16, 2025

Sold

Held Oct 16, 2026

Still held

Jeffrey Lightcap

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Jeffrey Lightcap are complete.

Director

n/a

Vesting, gifts, unvested awards and holding lines for Jeffrey Lightcap

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jeffrey Lightcap are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
16,075	$32.05	Jun 16, 2036	$282K

Estimate: options held × ($49.57 − strike price), using the most recent insider trade price on Form 4 (Oct 12, 2026), not a market close.

John Farquhar

Chief Executive Officer, Director

n/a

−350K

n/a

Vesting, gifts, unvested awards and holding lines for John Farquhar

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for John Farquhar are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−18Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
65,703	$8.33	Aug 24, 2031	$2.7M
102,739	$8.33	Mar 23, 2032	$4.2M
1,984,637	$2.22	Jul 10, 2033	$94.0M
182,043	$9.58	Dec 26, 2034	$7.3M
314,603	$19.00	Aug 7, 2035	$9.6M
321,259	$27.74	Feb 6, 2036	$7.0M

Estimate: options held × ($49.57 − strike price), using the most recent insider trade price on Form 4 (Oct 12, 2026), not a market close.

William Weldon

Director

n/a

Vesting, gifts, unvested awards and holding lines for William Weldon

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for William Weldon are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
34,246	$8.33	Mar 24, 2032	$1.4M
35,638	$2.22	Jul 10, 2033	$1.7M
57,078	$2.22	Sep 26, 2033	$2.7M
23,710	$19.00	Aug 7, 2035	$725K
16,075	$32.05	Jun 16, 2036	$282K

Estimate: options held × ($49.57 − strike price), using the most recent insider trade price on Form 4 (Oct 12, 2026), not a market close.

Timothy Barabe

Director

n/a

Vesting, gifts, unvested awards and holding lines for Timothy Barabe

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Timothy Barabe are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
15,412	$2.22	Jul 10, 2033	$730K
15,000	$19.00	Aug 7, 2035	$459K
16,075	$32.05	Jun 16, 2036	$282K

Estimate: options held × ($49.57 − strike price), using the most recent insider trade price on Form 4 (Oct 12, 2026), not a market close.

Campbell Rogers

Chief Medical Officer

n/a

−242K

n/a

Vesting, gifts, unvested awards and holding lines for Campbell Rogers

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Campbell Rogers are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−5.5Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
31,456	$8.33	Feb 28, 2030	$1.3M
2,231	$8.33	Apr 22, 2030	$92K
3,298	$8.33	Apr 12, 2031	$136K
70,783	$2.22	Jul 10, 2033	$3.4M
6,849	$2.22	Jul 10, 2033	$324K
82,972	$19.00	Aug 7, 2035	$2.5M
94,488	$27.74	Feb 6, 2036	$2.1M

Estimate: options held × ($49.57 − strike price), using the most recent insider trade price on Form 4 (Oct 12, 2026), not a market close.

Vikram Verghese

Chief Financial Officer

n/a

−99K

n/a

Vesting, gifts, unvested awards and holding lines for Vikram Verghese

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Vikram Verghese are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−5Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
7,849	$8.33	Mar 23, 2032	$324K
77,412	$2.22	Jul 10, 2033	$3.7M
66,588	$2.22	Dec 24, 2033	$3.2M
197,573	$9.58	Dec 26, 2034	$7.9M
110,629	$19.00	Aug 7, 2035	$3.4M
119,685	$27.74	Feb 6, 2036	$2.6M

Estimate: options held × ($49.57 − strike price), using the most recent insider trade price on Form 4 (Oct 12, 2026), not a market close.

Julie Cullivan

Director

n/a

−17K

n/a

Vesting, gifts, unvested awards and holding lines for Julie Cullivan

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Julie Cullivan are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
24,079	$2.22	Jul 10, 2033	$1.1M
23,710	$19.00	Aug 7, 2035	$725K
16,075	$32.05	Jun 16, 2036	$282K

Estimate: options held × ($49.57 − strike price), using the most recent insider trade price on Form 4 (Oct 12, 2026), not a market close.

Casey Tansey

Director

n/a

Vesting, gifts, unvested awards and holding lines for Casey Tansey

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Casey Tansey are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
47,420	$19.00	Aug 7, 2035	$1.4M
16,075	$32.05	Jun 16, 2036	$282K

Estimate: options held × ($49.57 − strike price), using the most recent insider trade price on Form 4 (Oct 12, 2026), not a market close.

Marie Jones

Chief Accounting Officer

n/a

Vesting, gifts, unvested awards and holding lines for Marie Jones

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Marie Jones are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−1.3Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
68,492	$12.68	Mar 13, 2035	$2.5M
19,014	$19.00	Aug 7, 2035	$581K
37,795	$27.74	Feb 6, 2036	$825K

Estimate: options held × ($49.57 − strike price), using the most recent insider trade price on Form 4 (Oct 12, 2026), not a market close.

Wayne Riley

Director

n/a

Vesting, gifts, unvested awards and holding lines for Wayne Riley

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Wayne Riley are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
17,123	$8.33	Mar 23, 2032	$706K
46,232	$2.22	Jul 10, 2033	$2.2M
23,710	$19.00	Aug 7, 2035	$725K
16,075	$32.05	Jun 16, 2036	$282K

Estimate: options held × ($49.57 − strike price), using the most recent insider trade price on Form 4 (Oct 12, 2026), not a market close.

Holdings and share of stake for Heartflow, Inc. are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$25.0M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $25.0M across 708,156 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $25.0M · 100%

Taxes

29,674 shares ($862K) were withheld by the company for taxes, which isn't a market sale.

Purchases · 1 buyer (1 trade)

1 officer or director bought shares in this period, in 1 trade(Form 4 code P, leaving out rows the filings describe as reinvested dividends, plan purchases, private deals or moves into the person's own trust). Across all their filings on record there is 1 purchase trade.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
John Farquhar Chief Executive Officer, Director	350K	$12.9M	100%	51%	Feb 10, 2026 to Oct 12, 2026
Campbell Rogers Chief Medical Officer	242K	$6.7M	100%	27%	Feb 12, 2026 to Sep 18, 2026
Vikram Verghese Chief Financial Officer	99K	$5.0M	100%	20%	Sep 2, 2026 to Sep 18, 2026
Julie Cullivan Director	17K	$447K	100%	2%	Feb 5, 2026 to Mar 5, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$0	$0	$0	$0
Dec 2025	$0	$0	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$2.4M	$2.4M	$0	$0
Mar 2026	$2.4M	$2.4M	$0	$0
Apr 2026	$2.2M	$2.2M	$0	$0
May 2026	$918K	$918K	$0	$0
Jun 2026	$2.0M	$2.0M	$0	$0
Jul 2026	$863K	$863K	$0	$0
Aug 2026	$4.5M	$4.5M	$0	$0
Sep 2026	$7.8M	$7.8M	$0	$0
Oct 2026	$1.9M	$1.9M	$0	$0

Board members representing outside shareholders (2)Listed and sourced; not part of the management totals or the answer line

Directors whose reported holdings sit mostly in an investment fund or a corporate shareholder they represent, not in their own name, with beneficial ownership disclaimed except for their own financial interest. Listed and sourced here; not part of the management totals or the answer line. Shares a fund hands to its own investors are distributions, not sales.

Board member	Held Oct 16, 2025	Sold	Held Oct 16, 2026	Still held
Casey Tansey ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Casey Tansey are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Casey Tansey Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Casey Tansey are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts)
Jeffrey Lightcap ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Jeffrey Lightcap are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Jeffrey Lightcap Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jeffrey Lightcap are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts)

Known gaps and uncertainty10 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Heartflow, Inc. are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology88 filings on record, 63 filed in the 12-month period, and how we read them

All 88 Forms 3, 4 and 5 on record for Heartflow, Inc. (SEC CIK 1464521), filed from Aug 7, 2025 to Oct 14, 2026; 63 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 16, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (1)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Nicholas Downing		No balance on record

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Heartflow, Inc. insiders sold $25.0M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Recent activity

Outside holders, reported separately

Common questions

Is the Heartflow, Inc. CEO selling stock?

Why are Heartflow, Inc. insiders selling?

Are any Heartflow, Inc. insiders buying?

The evidence

Taxes

Purchases · 1 buyer (1 trade)

Sales by month